65,437 trials
Behavior Problem · Parenting
Primary: Child Screen Media Use (Time) — 210.00; 267.86; 163.57; 290.00 minutes per weekend day — p=.29
Dry Eye Syndromes · Dry Eye · Meibomian Gland Dysfunction
Primary: Score and Change From Baseline in Tear Break Up Times (TBUT), as Assessed by a Masked Rater — 4.0; 1.9; 3.4; 4.7 seconds
Brain Injuries, Traumatic · Transitional Care · Family Members
Primary: Change in Quality of Life as Measured by the Short Form-36 (SF-36) — 47.97 score on a scale
Edentulism
Primary: Marginal Bone Level Change — -0.25; -0.2 mm
Healthy
Primary: Blood Pressure During Exercise Between Study Arms — 142; 146 mmHg
Diabetes Mellitus, Type 2
Primary: Incidence Rates of Acute Liver Injury (ALI) in Patients With no Predisposing Conditions (ALI1) in Propensity Score-trimmed Cohort for ALI1 — 0.60; 1.21; 1.09; NA Events…
Esophageal Squamous Cell Carcinoma
Primary: Complete Pathologic Response Rate — 6 Participants
Alcohol Use Disorder · Early Trauma Complications
Primary: Brain Response — .015; .010; -.013; .08 unitless — p=<0.05
Smoking Cessation
Primary: Percentage of Participants With Smoking Abstinence From Weeks 3 to Week 6 — 4.4; 25.3 percentage of participants — p=< 0.0001
Depressive Disorder, Major
Primary: Mean Percent Change From Baseline in MADRS Score — -7.7; -7.4; -8.8; -6.2 percentage change from baseline
Chronic Pain
Primary: Pain Relief- Change in VAS Pain Intensity From Baseline to Post Implantation — 7.5; 4.4; 5.2; 4.7 cm
Chronic Low Back Pain · Chronic Neck Pain
Primary: Overall Opioid Dose (Morphine-equivalent Dose in mg) — 19.6; 19.6; 19.6 mg
Heart Failure
Primary: Freedom From Death or Hemocompatibility Related Adverse Events (Stroke, Device Thrombosis, Bleeding, Aortic Root Thrombus, and Arterial Non-CNS Thromboembolism) — 16; 12…
Peripheral Arterial Disease · Intermittent Claudication
Primary: Tolerability Test - Related Withdrawals — 1; 3 Participants
Insomnia
Primary: Rates of Hypnotic Discontinuation — 48; 36 Participants — p=0.056